Burcon Receives Notice of Allowance for CLARISOY(TM) Composition of Matter Patent
February 05 2014 - 8:30AM
Burcon NutraScience Corporation, (TSX:BU)
(Nasdaq:BUR)
("Burcon") a leader in functional and
renewable plant protein ingredients, has received a notice of
allowance from the United States Patent and Trademark Office for an
important and commercially strategic CLARISOY™ patent application.
The importance and strategic value of this patent derive from the
numerous specific composition of matter claims that have been
allowed. The composition of matter claims provide protection over
the commercially valuable attributes of CLARISOY™. This marks the
first ever CLARISOY™ composition of matter claims to be allowed.
A notice of allowance from the United States Patent and
Trademark Office is a written notification that a patent
application has cleared internal review and will proceed to grant
as a U.S. patent.
CLARISOY™ is Burcon's proprietary and revolutionary soy-based
protein. CLARISOY™ is under exclusive license to Archer
Daniels Midland Company ("ADM"). ADM's CLARISOY™ line includes
a range of products for both low and neutral pH
applications.
"Composition of matter patents are considered to be the most
valuable type of patent because they cover any use of the claimed
matter, regardless of the process by which it was produced or how
it is being used," noted Johann Tergesen, Burcon's president and
COO. "So, unlike application or process patents where it can be
more difficult to establish that an infringement has occurred,
enforcing composition of matter patents simply requires that the
matter in question demonstrates the same beneficial characteristics
of the matter that is patent-protected. For CLARISOY™, these
characteristics, amongst others, are its unique solubility and
transparency in solution, and absence of taste or smell."
This new patent allowance reflects Burcon's extensive investment
in developing its intellectual property portfolio, which includes
the full range of composition of matter, application and process
patents and patent applications. Including the new CLARISOY™
patent, Burcon's intellectual property portfolio will be comprised
of 255 patents in various countries, with 52 in the U.S., as well
as more than 450 active patent applications, including 85 in the
U.S.
"This new composition of matter patent represents a major step
in protecting the intellectual property that supports the unique
competitive advantages of CLARISOY™," continued Mr. Tergesen. "Our
patenting efforts will remain a major area of focus in 2014, as
will be our continued pursuit of perfecting the science that makes
our proteins already so exceptional."
About CLARISOY™ Soy Protein
CLARISOY™ soy protein, which is under exclusive license to
Archer Daniels Midland Company ("ADM"), is the world's only
soy-based protein capable of offering both clarity and high-quality
protein nutrition in low pH beverage systems.
ADM's CLARISOY™ line includes a range of products for both low
and neutral pH applications allowing food and beverage companies to
easily include up to 10 grams of CLARISOY™ per 500mL serving.
CLARISOY™ 100 is a premier soy-based protein that offers both
clarity and high-quality protein nutrition for beverages with a pH
of less than 4. Extremely heat stable, CLARISOY™ 100 requires
no homogenization or stabilizers in low pH beverages.
CLARISOY™ 150 is a revolutionary soy protein for neutral pH
beverages and low pH beverages with cloud systems. The clean
flavor and smooth mouth-feel makes CLARISOY™ 150 a formulator's
ideal protein ingredient.
For more information about CLARISOY™,
visit www.clarisoy.com.
About Burcon NutraScience Corporation
Burcon NutraScience is a leader developing functionally superior
plant-based proteins. The company has developed a portfolio of
composition, application, and process patents originating from a
core protein extraction and purification technology. Burcon's
CLARISOY™ soy protein offers clarity and high-quality protein
nutrition for low pH beverage systems; Peazazz® is a uniquely
soluble and clean-tasting pea protein; and Puratein®, Supertein™
and Nutratein® are canola protein isolates with unique functional
and nutritional attributes. For more information about the company,
visit www.burcon.ca.
ON BEHALF OF THE BOARD OF DIRECTORS "Johann F.
Tergesen" Johann F. Tergesen President and Chief Operating
Officer
The TSX has not reviewed and does not accept responsibility for
the adequacy of the content of the information contained herein.
This press release contains forward-looking statements or
forward-looking information. Forward-looking statements or
forward-looking information involve risks, uncertainties and other
factors that could cause actual results, performances, prospects
and opportunities to differ materially from those expressed or
implied by such forward-looking statements. All statements other
than statements of historical fact included in this release are
forward-looking statements, including, without limitation,
statements regarding plans and timing for the introduction or
enhancement of our products, statements about future market
conditions, supply and demand conditions, and other expectations,
intentions and plans contained in this press release. There can be
no assurance that such statements will prove to be accurate and
actual results and future events could differ materially from those
anticipated in such statements or information. Important factors
that could cause actual results to differ materially from Burcon's
plans and expectations include the actual results of marketing
activities, adverse general economic, market or business
conditions, regulatory changes and other risks and factors detailed
herein and from time to time in the filings made by Burcon with
securities regulators and stock exchanges, including in the section
entitled "Risk Factors" in Burcon's annual information form dated
June 25, 2013. Any forward-looking statement or information
only speaks as of the date on which it was made and, except as may
be required by applicable securities laws, Burcon disclaims any
intent or obligation to update any forward-looking statement,
whether as a result of new information, future events or otherwise.
Although Burcon believes that the assumptions inherent in the
forward-looking statements are reasonable, forward-looking
statements are not guarantees of future performance and accordingly
undue reliance should not be put on such.
CLARISOY is a trademark of Archer Daniels Midland Company.
CONTACT: Media & Industry Contact:
Michael Kirwan
Director, Corporate Development
Burcon NutraScience Corporation
Tel 604-733-0896, Toll-free 888-408-7960
mkirwan@burcon.ca
www.burcon.ca
Investor Relations Contact:
Michael Koehler or Matt Glover
Liolios Group Inc.
Tel 949-574-3860
BUR@liolios.com
Burcon NutraScience (TSX:BU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Burcon NutraScience (TSX:BU)
Historical Stock Chart
From Jul 2023 to Jul 2024